PortfoliosLab logoPortfoliosLab logo
Inception Date
Aug 4, 2016
Region
Global (Broad)
Leveraged
1x (No leverage)
Index Tracked
Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Domicile
Australia
Distribution Policy
Distributing
Asset Class
Equity
Asset Class Size
Large-Cap

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

DRUG.AX Performance Chart

Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) is down 0.4% since the beginning of the year. DRUG.AX is currently trading at A$8 per share. Investors who bought A$1,000 worth of DRUG.AX shares 5 years ago would now be looking at an investment worth A$1,196.


Loading charts...

S&P 500 Index

Returns By Period

Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) has returned -0.40% so far this year and 14.00% over the past 12 months.


Betashares Global Healthcare Currency Hedged ETF

1D
0.12%
1M
1.68%
6M
-1.74%
YTD
-0.40%
1Y
14.00%
3Y*
5.36%
5Y*
3.65%
10Y*

Benchmark (S&P 500 Index)

1D
0.12%
1M
1.38%
6M
4.49%
YTD
5.58%
1Y
12.98%
3Y*
18.01%
5Y*
13.12%
10Y*
14.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DRUG.AX Monthly Returns History

Based on dividend-adjusted daily data since Aug 4, 2016, DRUG.AX's average daily return is +0.03%, while the average monthly return is +0.64%. At this rate, an investment would double in approximately 9.1 years.

Historically, 57% of months were positive and 43% were negative. The best month was Apr 2020 with a return of +12.6%, while the worst month was Dec 2018 at -8.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, DRUG.AX closed higher 47% of trading days. The best single day was Nov 10, 2016 with a return of +8.2%, while the worst single day was Feb 6, 2018 at -8.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.68%2.06%-6.17%-2.39%4.04%5.54%-2.29%-0.40%
20256.49%0.96%-2.96%-4.39%-3.70%0.53%0.26%2.50%-1.03%5.57%8.47%-0.57%11.83%
20243.66%3.90%1.64%-3.58%1.32%4.01%2.13%3.99%-3.29%-2.83%-2.22%-6.21%1.82%
2023-3.05%-1.97%1.61%3.43%-2.93%1.57%1.94%0.89%-2.26%-5.40%3.67%3.80%0.76%
2022-7.72%-1.86%8.39%-2.00%-0.38%-3.96%3.60%-5.14%-2.85%7.25%2.47%-0.25%-3.68%
20211.83%-2.13%2.90%3.10%2.19%3.88%3.10%3.80%-4.29%2.11%-0.52%5.84%23.60%

Benchmark Metrics

Betashares Global Healthcare Currency Hedged ETF has an annualized alpha of 6.87%, beta of 0.06, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since August 04, 2016.

  • This ETF participated in 74.90% of S&P 500 Index downside but only 54.04% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.06 may look defensive, but with R2 of 0.00 this ETF is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
  • R2 of 0.00 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.87%
Beta
0.06
0.00
Upside Capture
54.04%
Downside Capture
74.90%

Expense Ratio

DRUG.AX has an expense ratio of 0.57%, placing it in the medium range.


Return for Risk

Risk / Return Rank

DRUG.AX ranks 34 for risk / return — below 34% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


DRUG.AX Risk / Return Rank: 3434
Overall Rank
DRUG.AX Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
DRUG.AX Sortino Ratio Rank: 3737
Sortino Ratio Rank
DRUG.AX Omega Ratio Rank: 3333
Omega Ratio Rank
DRUG.AX Calmar Ratio Rank: 3636
Calmar Ratio Rank
DRUG.AX Martin Ratio Rank: 3030
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DRUG.AXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-0.25

Sortino ratioReturn per unit of downside risk

-0.15

Omega ratioGain probability vs. loss probability

1.19

1.24

-0.05

Calmar ratioReturn relative to maximum drawdown

1.50

1.11

+0.38

Martin ratioReturn relative to average drawdown

3.58

3.10

+0.48

Dividends

Dividend History

Betashares Global Healthcare Currency Hedged ETF provided a 3.69% dividend yield over the last twelve months, with an annual payout of A$0.31 per share.


0.00%1.00%2.00%3.00%4.00%A$0.00A$0.10A$0.20A$0.30A$0.4020182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018
DividendA$0.31A$0.00A$0.22A$0.00A$0.00A$0.37A$0.04A$0.02A$0.18

Dividend yield

3.69%0.00%2.84%0.00%0.00%4.49%0.62%0.28%3.37%

Monthly Dividends

The table displays the monthly dividend distributions for Betashares Global Healthcare Currency Hedged ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.31A$0.31
2025A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00
2024A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.22A$0.00A$0.00A$0.00A$0.00A$0.00A$0.22
2023A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00
2022A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00
2021A$0.02A$0.00A$0.00A$0.00A$0.00A$0.00A$0.35A$0.00A$0.00A$0.00A$0.00A$0.00A$0.37

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Betashares Global Healthcare Currency Hedged ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Betashares Global Healthcare Currency Hedged ETF was 26.79%, occurring on Mar 23, 2020. Recovery took 83 trading sessions.

The current Betashares Global Healthcare Currency Hedged ETF drawdown is 4.42%.


Drawdown

Fall

Recovery

Underwater

Related event

-26.79%Mar 2020
2mo4mo
6moJan 2020 - Jul 2020
COVID crash2020
-20.63%May 2025
8mo 14d
1y 10moSep 2024 - now
2025 selloff2025
-14.98%Sep 2022
5mo 19d1y 4mo
1y 9moApr 2022 - Feb 2024
Bear market2022
-13.42%Feb 2018
7d5mo 21d
5mo 28dJan 2018 - Jul 2018
-12.66%Dec 2018
20d10mo 10d
11moDec 2018 - Oct 2019
Rate-hike selloffLate 2018

Drawdown Indicators


DRUG.AXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-26.79%

-41.07%

+14.28%

Max Drawdown (1Y)

Largest decline over 1 year

-10.69%

-11.69%

+1.00%

Max Drawdown (3Y)

Largest decline over 3 years

-20.63%

-17.74%

-2.89%

Max Drawdown (5Y)

Largest decline over 5 years

-20.63%

-22.01%

+1.38%

Max Drawdown (10Y)

Largest decline over 10 years

-24.71%

Current Drawdown

Current decline from peak

-4.42%

-0.60%

-3.82%

Average Drawdown

Average peak-to-trough decline

-5.17%

-11.02%

+5.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.52%

4.20%

+0.32%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with DRUG.AX

Add Betashares Global Healthcare Currency Hedged ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with DRUG.AX